CD44v6 in developing, dysplastic and malignant oral epithelia

By Rautava J.   Soukka T.   Inki P.   Leimola-Virtanen R.   Saloniemi I.   Happonen R.-P.   Heikinheimo K.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 373-379

Elsevier

Access to resources Recommend Favorite

IGF-1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin

By    

Molecular Medicine Reports, Vol. 6, Iss. 6, 2012-01 ,pp. : 1433-1437

Spandidos Publications

Access to resources Recommend Favorite

The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia

By Ries Jutta   Vairaktaris Eleftherios   Agaimy Abbas   Bechtold Moritz   Gorecki Patricia   Neukam Friedrich W.   Nkenke Emeka  

Oncology Reports, Vol. 30, Iss. 3, 2013-09 ,pp. : 1149-1156

Spandidos Publications

Access to resources Recommend Favorite

Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions

By Partridge M.   Emilion G.   Pateromichelakis S.   Phillips E.   Langdon J.  

European Journal of Cancer. Part B: Oral Oncology, Vol. 33, Iss. 5, 1997-09 ,pp. : 332-337

Elsevier

Access to resources Recommend Favorite

Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas

By Wu Pei-Fang   Huang Wen-Chang   Yang James   Lu Yen-Shen   Shih Jin-Yuan   Wu Shang-Gin   Lin Ching-Hung   Cheng Ann-Lii  

Journal of Neuro-Oncology, Vol. 115, Iss. 1, 2013-10 ,pp. : 61-70

Springer Publishing Company

Access to resources Recommend Favorite